The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ta ting lei jiang zhi xin yao luo su fa ta ting de lin chuang ying yong
Author(s): 
Pages: 28-30
Year: Issue:  1
Journal: WORLD CLINICAL DRUGS

Keyword:  HMG-CoA还原酶抑制剂血脂异常罗苏伐他汀rosuvastatin他汀类;
Abstract: 罗苏伐他汀是他汀类药物中的新品,具有与其他药物相互作用小,且甚少进行代谢转化的特性.多项历时6周至1年的多中心随机双盲对照研究显示,本品对高胆固醇血症患者的疗效优于阿托伐他汀、辛伐他汀和普伐他汀.研究还显示,罗苏伐他汀对杂合型和纯合型家族性高胆固醇血症、高甘油三酯血症或混合性脂质异常患者均有一定疗效.另外,本品还具有良好的耐受性.
Related Articles
No related articles found